EP Patent

EP3992631A1 — Methods of diagnosing and/or prognosing a disease in tear sample

Assigned to Ideogen Ag · Expires 2022-05-04 · 4y expired

What this patent protects

The invention relates to methods of diagnosing, prognosing, stratifying, or determining the progression or regression of a disease, based on the detection of one or more metabolite profile(s) in tears.

USPTO Abstract

The invention relates to methods of diagnosing, prognosing, stratifying, or determining the progression or regression of a disease, based on the detection of one or more metabolite profile(s) in tears.

Drugs covered by this patent

Patent Metadata

Patent number
EP3992631A1
Jurisdiction
EP
Classification
—
Expires
2022-05-04
Drug substance claim
No
Drug product claim
No
Assignee
Ideogen Ag
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.